Table 4.
Diagnosis and first-line treatment among different respondent groups. X2 test is used for the group comparison. Statistically significant difference (p<0.05) appear in bold
| Anaphylaxis diagnosis OR 95% CI | p Value | Intramuscular adrenalin OR 95% CI | p Value | Prednisolone OR 95% CI | p Value | Chloropyramine OR 95% CI | p Value | |
| Sex | 0.75 (0.36 to 1.57) | 0.45 | 0.71 (0.24 to 2.10) | 0.54 | 1.69 (0.85 to 3.83) | 0.14 | 1.49 (0.70 to 3.15) | 0.30 |
| Age | 0.97 (0.95 to 1.00) | 0.10 | 0.98 (0.94 to 1.03) | 0.42 | 1.00 (0.98 to 1.04) | 0.61 | 0.97 (0.93 to 0.99) | 0.04 |
| Specialty | 1.34 (0.77 to 2.35) | 0.31 | 1.30 (0.60 to 2.83) | 0.51 | 1.43 (0.82 to 2.50) | 0.20 | 1.59 (0.85 to 2.97) | 0.15 |
| Clinical settings | 0.51 (0.30 to 0.86) | 0.01 | 0.74 (0.36 to 1.50) | 0.40 | 1.55 (0.90 to 2.68) | 0.11 | 0.95 (0.52 to 1.73) | 0.86 |
| Clinical experience | 1.33 (0.59 to 2.99) | 0.49 | 1.39 (0.45 to 4.31) | 0.57 | 0.94 (0.43 to 2.05) | 0.88 | 1.93 (0.81 to 4.61) | 0.14 |
| Anaphylaxis diagnosis | NA | NA | 5.65 (2.81 to 11.36) | <0.01 | 0.73 (0.44 to 1.24) | 0.24 | 0.35 (0.19 to 0.67) | <0.01 |